1 |
N. Kohri, K. Miyazaki, T. Arita, H. Shimono, A. Nomura and H. Yasuda, Release characteristics of nifedipine sustained-release granules in vitro and in healthy subjects, Chem. Pharm. Bull., 35, 2504-2509 (1987)
DOI
ScienceOn
|
2 |
L.A. Syed, Nifedipine, Analytical Profiles of Drug Substances, 18, 221-288 (1989)
|
3 |
C.H. Kleinbloesem, P. Brummelen, J.A. Linde, P.J. Voogd and D.D. Breimer, Nifedipine: Kinetics and dynamics in healthy subjects, Clin. Pharmacol. Ther., 35, 742-749 (1984)
DOI
ScienceOn
|
4 |
D. Murdoch and R.N. Brogden, Sustained release nifedipine formulations, Drugs, 41, 737-779 (1991)
DOI
ScienceOn
|
5 |
G. Yan, H. Li, R. Zhang and D. Ding, Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets, Drug Dev. Ind. Pharm., 26, 681-686 (2000)
DOI
ScienceOn
|
6 |
S.E. Leucuta, The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man, Die Pharmazie, 43, 845-848 (1988)
|
7 |
K. Tateshita, S. Sugawara, T. Imai and M. Otagiri, Prepara- tion and evaluation of a controlled-release formulation of nifedipine using alginate gel beads, Bio. Pharm. Bull., 16, 420-424 (1993)
DOI
ScienceOn
|
8 |
T. Chandy and C.P. Sharma, Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies, Biomaterials, 13, 949-952 (1992)
DOI
ScienceOn
|
9 |
G.J. Filipovic, L.M. Becirevic, N. Skalko and I. Jalsenjak, Chitosan microsheres of nifedipine and nifedipine-cyclo- dextrin inclusion complexes, Int. J. Pharm., 135, 183-190 (1996)
DOI
ScienceOn
|
10 |
S.E. Leucuta, Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man, J. Microencapsul., 7, 209-217 (1990)
DOI
|
11 |
A. Barkai, Y.V. Pathak and S. Benita, Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization, Drug Dev. Ind. Pharm., 16, 2057-2075 (1990)
DOI
|
12 |
K.P.R. Chowdary and S.G. Girija, Eudragit microcapsules of nifedipine and its dispersions in HPMC-MCC : Physicochemi- cal characterization and drug release studies, Drug Dev. Ind. Pharm., 23, 325-330 (1997)
DOI
ScienceOn
|
13 |
W.H. Chuo, T.R. Tsai, S.H. Hsu and T.M. Cham, Preparation and in-vitro evaluation of nifedipine loaded albumin micro- spheres cross-linked by different glutaraldehyde concentra- tions, Int. J. Pharm., 144, 241-245 (1996)
DOI
ScienceOn
|
14 |
L. Maggi, M.L. Torre, P. Giunchedi and U. Conte, Suprami- cellar solutions of sodium dodecyl sulphate as dissolution media to study the in vitro release characteristics of sustained-release formulations containing an insoluble drug: nifedipine, Int. J. Pharm., 135, 73-79 (1996)
DOI
ScienceOn
|
15 |
F. Carli, G. Capone, I. Colombo, L. Magarotto and A. Motta, Surface and transport properties of acrylic polymers influen- cing drug release from porous matrices, Int. J. Pharm., 21, 317-329 (1984)
DOI
ScienceOn
|
16 |
Z. Wang, T. Horikawa, F. Hirayama and K. Uekama, Design and in vitro evaluation of a modified-release oral dosage form of nifedipine by hybriation of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose, J. Pharm. Pharmacol., 45, 942-946 (1993)
DOI
ScienceOn
|
17 |
J.W. Moore and H.H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Tech., 20, 64-74 (1996)
|
18 |
P.R.P. Vera and V. Banu, Sustained release of theophylline from Eudragit RLPO and RSPO tablets, Drug Dev. Ind. Pharm., 22, 1243-1247 (1996)
DOI
ScienceOn
|
19 |
R. Bodmeier, X. Guo, R.E. Sarabia and P.F. Skultety, The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D, Pharm. Res., 13, 52-56 (1996)
DOI
ScienceOn
|
20 |
M.R. Jenquin, S.M. Liebowitz, R.E. Sarabia and J.W. Mc- Ginity, Physical and chemical factors influencing the release of drugs from acrylic resin films, J. Pharm. Sci., 79, 811-816 (1990)
DOI
|